Position in RGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$301,370
New position
Shares Held
11,851
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 66%
Shared 0%
None 34%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $7,768,199,773 across 50 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
19,667,723 | $1,413,322,574 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,898,064 | $1,028,428,017 | |
| 3 | VTRS |
Viatris Inc
|
53,069,461 | $842,743,040 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
4,385,598 | $739,148,686 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,936,548 | $641,570,246 | |
| 6 | ALKS |
Alkermes plc.
|
9,160,575 | $480,014,130 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
16,063,046 | $395,311,562 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
8,145,699 | $282,411,384 |
All Filings in RGC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $301,370 | 11,851 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||